Skip to main content
TipRanks
Go Ultimate75% OFF

Avantor (AVTR) AI Stock Analysis

479 Followers
AVTR

Avantor

(NYSE:AVTR)

Select Model
Rating:68Neutral
Price Target:$18.00â–²(17.49% Upside)
Action:reiterated
Date:10/29/26

AVTR scores as moderately attractive, led by improving fundamentals (profitability and leverage stabilizing with solid cash generation) and supportive technical momentum (price above key moving averages with positive MACD). The earnings call adds confidence via raised guidance and strong free cash flow, while the main constraint on the score is valuation risk given the high P/E and no dividend support.

Positive Factors
Return to organic growthThe return to organic growth across the company indicates improving demand and execution after a period of weaker performance. Raised full-year guidance and positive fourth-quarter assumptions suggest the recovery may extend beyond one quarter and support more durable revenue momentum.
Negative Factors
Margin pressureIf pricing continues to lag cost inflation, revenue growth may not translate efficiently into earnings or cash flow. Mix effects from faster growth in lower-margin VWR and ongoing investment needs could keep margins below prior peaks and limit profitability recovery.

Avantor Key Performance Indicators (KPIs)

Revenue by SegmentShows how much each business segment contributes to total revenue, indicating the company’s diversification and which segments are leading growth or facing headwinds.

$0.00$500.00M$1.00B$1.50BMar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Avantor resegmented reporting in 2026, shifting legacy Laboratory Solutions/Bioscience Production into VWR Distribution & Services and Bioscience & Medtech Products—an important change because VWR is now the larger, accelerating revenue engine (returned to organic growth) while BMP carries discrete, near‑term order normalization and electronic‑materials headwinds despite a healthy book‑to‑bill. Management’s raised guidance and cash generation hinge on VWR momentum and BMP converting backlog in H2; watch those two drivers plus FX and leverage progress for upside.

Data provided by:The Fly

Avantor (AVTR) vs. SPDR S&P 500 ETF (SPY)

-40%-20%0%20%40%60%AVTR+39.15%SPY+13.31%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$10.38B
Dividend Yield
―
Average Volume (3M)
8.69M
Price to Earnings (P/E)
30.7
Beta (1Y)
0.89
Revenue Growth
0.92%
EPS Growth
―
Country
US
Employees
13,500
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Avantor Business Overview & Revenue Model

Company Description

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array...

How the Company Makes Money

Avantor primarily makes money by selling products and services used in laboratory research, testing, and biopharmaceutical manufacturing. Its revenue is largely generated from (1) consumables and repeat-purchase items (e.g., chemicals, reagents, lab...

Avantor Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:-10.57%|Next Earnings Date:Feb 04, 2027
Earnings Call SentimentPositive

The call was strongly constructive. Avantor reported a return to organic growth, outperformance in both revenue and adjusted EPS, positive performance in VWR and BMP, robust free cash flow, lower leverage, improved order trends, and raised full-year guidance. The main challenges were mix and inflationary margin pressure, foreign-exchange headwinds, BMP comparison effects, pricing that remains below inflation, and a lagging European market. Highlights significantly outweighed the lowlights.

Positive Updates

Return to Organic Revenue Growth
Avantor generated third-quarter revenue of $1.698 billion, representing 5.2% year-over-year organic growth and 4.6% reported growth, exceeding expectations. Management described the quarter as Avantor's return to organic revenue growth and an important milestone in the Revival program.

Negative Updates

Margin Pressure from Mix and Inflation
VWR adjusted operating income was $119 million, with a 9.7% adjusted operating margin. VWR's year-over-year and sequential operating-margin declines primarily reflected mix, inflationary pressures, and growth investments. Company-wide margins also faced pressure because VWR grew faster than BMP and has a lower gross-margin profile.

Company Guidance

For full year 2026, Avantor raised its organic revenue growth outlook to a range of 0.75 to 1.25%, with Q4 organic revenue growth implied at 2.5 to 4.5%; foreign exchange is expected to be a headwind of 150 basis points to reported revenue in Q4 and contribute approximately 75 basis points to full year reported revenue growth. VWR is expected to grow mid single digits in Q4, while BMP is expected to deliver year over year organic growth that is flat to slightly positive, reflecting approximately 400 basis points of headwind from discrete comparisons, with modest sequential growth from Q3 to Q4. Adjusted EBITDA margin guidance remains unchanged and is expected to expand modestly from Q3 to Q4; the adjusted effective tax rate is expected to be between 22% and 22.5%, weighted average diluted share count is expected to be 679 million shares, adjusted EPS guidance is $0.81 to $0.83, and free cash flow guidance is between $520 million and $550 million in 2026, with the adjusted net leverage ratio expected to be below 3x by year end.

Avantor Financial Statement Overview

Summary

Financials look stabilized rather than fully re-accelerating: TTM profitability returned to positive territory after a weak 2025, leverage is improving, and operating/free cash flow remain consistently positive. Offsetting this, multi-year revenue has been flat-to-down and margins are meaningfully below 2022–2024 levels, with limited near-term cash-flow momentum.

Income Statement

60Neutral

Balance Sheet

68Positive

Cash Flow

66Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.64B6.55B6.78B6.97B7.51B7.39B
Gross Profit2.10B2.14B2.28B2.36B2.60B2.50B
EBITDA909.30M138.70M1.48B1.10B1.52B1.35B
Net Income337.20M-530.20M711.50M321.10M686.50M572.60M
Balance Sheet
Total Assets11.63B11.79B12.11B12.97B13.46B13.90B
Cash, Cash Equivalents and Short-Term Investments464.30M365.40M261.90M262.90M372.90M301.70M
Total Debt3.68B3.95B4.06B5.54B6.29B7.02B
Total Liabilities5.79B6.23B6.16B7.72B8.61B9.70B
Stockholders Equity5.84B5.57B5.96B5.25B4.86B4.20B
Cash Flow
Free Cash Flow439.20M495.00M692.00M723.60M710.20M842.50M
Operating Cash Flow584.70M623.80M840.80M870.00M843.60M953.60M
Investing Cash Flow-148.20M-130.50M438.90M-143.70M-109.60M-4.12B
Financing Cash Flow-217.10M-409.40M-1.28B-843.70M-648.70M3.22B

Avantor Technical Analysis

Technical Analysis SentimentNegative
Last Price15.32

Price Trends

50DMA15.71Negative
100DMA14.16Positive
200DMA11.41Positive

Market Momentum

MACD-0.10Positive
RSI42.36Neutral
STOCH37.80Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVTR, the sentiment is Negative. The current price of 15.32 is below the 20-day moving average (MA) of 16.17, below the 50-day MA of 15.71, and above the 200-day MA of 11.41, indicating a neutral trend. The MACD of -0.10 indicates Positive momentum. The RSI at 42.36 is Neutral, neither overbought nor oversold. The STOCH value of 37.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVTR.

Avantor Risk Analysis

Avantor disclosed 39 risk factors in its most recent earnings report. Avantor reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Our VWR Distribution reporting unit is at risk of goodwill impairment, which could result in a material non-cash charge.Q2, 2026
2.Our VWR Distribution reporting unit is at risk of goodwill impairment, which could result in a material non-cash charge.Q1, 2026
3.Our business could be impacted as a result of actions by activist shareholders or others.Q4, 2025

Avantor Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

AVTR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
WSTWST78Outperform$29.10B46.4621.08%0.22%12.60%32.05%
AVTRAVTR68Neutral$10.38B30.705.96%―0.92%―
AZTAAZTA63Neutral$2.07B-13.00-10.81%―4.65%-196.27%
STVNSTVN55Neutral$4.24B27.869.07%0.40%11.99%4.96%
RGENRGEN54Neutral$10.41B-779.19-0.56%―13.80%-811.00%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%AVTRAZTARGENWSTSTVNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AVTR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AVTRAvantor15.324.1837.52%
AZTAAzenta, Inc.47.2217.8060.50%
RGENRepligen162.789.726.35%
WSTWest Pharmaceutical Services, Inc.417.80158.4361.08%
STVNStevanato Group Spa15.53-5.23-25.21%

Avantor Corporate Events

Business Operations and StrategyExecutive/Board Changes

Avantor Names Todd Garner as New Chief Financial Officer

Positive
Sep 21, 2026

On September 21, 2026, Avantor, Inc. appointed Todd Garner as Executive Vice President and Chief Financial Officer, with Garner joining the Executive Leadership Team as the company’s principal financial officer. The move ends the interim CFO tenure o...

Business Operations and StrategyExecutive/Board Changes

Avantor Appoints Todd Garner as New Chief Financial Officer

Positive
Sep 21, 2026

On September 21, 2026, Avantor announced that Todd Garner was appointed Executive Vice President and Chief Financial Officer, joining the executive leadership team and serving as the company’s principal financial officer. He will oversee global finan...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 29, 2026